Literature DB >> 22401910

Larazotide acetate promotes tight junction assembly in epithelial cells.

Shobha Gopalakrishnan1, Amit Tripathi, Amir P Tamiz, Sefik S Alkan, Niranjan B Pandey.   

Abstract

Tight junctions (TJ) control paracellular permeability and apical-basolateral polarity of epithelial cells. Dysregulated permeability is associated with pathological conditions, such as celiac disease and inflammatory bowel disease. TJ formation is dependent on E-cadherin-mediated cell-cell adhesion and actin rearrangement, and is regulated by the Rho family GTPase and aPKC signaling pathways. Larazotide acetate, an 8-mer peptide and TJ modulator, inhibits TJ disassembly and dysfunction caused by endogenous and exogenous stimuli in intestinal epithelial cells. Here, we examined the effect of larazotide acetate on de novo TJ assembly using 2 different model systems. In MDCK cells, larazotide acetate promoted TJ assembly in a calcium switch assay. Larazotide acetate also promoted actin rearrangement, and junctional distribution of zonula occludens-1 (ZO-1), occludin, claudins, and E-cadherin. Larazotide acetate promoted TJ maturation and decreased paracellular permeability in "leaky" Caco-2 cells. Taken together, our data indicate that larazotide acetate enhances TJ assembly and barrier function by promoting actin rearrangement and redistribution of TJ and AJ proteins.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22401910     DOI: 10.1016/j.peptides.2012.02.016

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  20 in total

1.  Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial.

Authors:  Daniel A Leffler; Ciaran P Kelly; Peter H R Green; Richard N Fedorak; Anthony DiMarino; Wendy Perrow; Henrik Rasmussen; Chao Wang; Premysl Bercik; Natalie M Bachir; Joseph A Murray
Journal:  Gastroenterology       Date:  2015-02-13       Impact factor: 22.682

Review 2.  Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases.

Authors:  Craig Sturgeon; Alessio Fasano
Journal:  Tissue Barriers       Date:  2016-10-21

Review 3.  The potential utility of tight junction regulation in celiac disease: focus on larazotide acetate.

Authors:  Shahryar Khaleghi; Josephine M Ju; Abhinav Lamba; Joseph A Murray
Journal:  Therap Adv Gastroenterol       Date:  2016-01       Impact factor: 4.409

Review 4.  The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics.

Authors:  Carlos R Camara-Lemarroy; Luanne Metz; Jonathan B Meddings; Keith A Sharkey; V Wee Yong
Journal:  Brain       Date:  2018-07-01       Impact factor: 13.501

5.  A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challenge.

Authors:  Daniel A Leffler; C P Kelly; H Z Abdallah; A M Colatrella; L A Harris; F Leon; L A Arterburn; B M Paterson; Z H Lan; J A Murray
Journal:  Am J Gastroenterol       Date:  2012-07-24       Impact factor: 10.864

Review 6.  The present and the future in the diagnosis and management of celiac disease.

Authors:  Natalia E Castillo; Thimmaiah G Theethira; Daniel A Leffler
Journal:  Gastroenterol Rep (Oxf)       Date:  2014-10-17

7.  BL-7010 demonstrates specific binding to gliadin and reduces gluten-associated pathology in a chronic mouse model of gliadin sensitivity.

Authors:  Justin L McCarville; Yotam Nisemblat; Heather J Galipeau; Jennifer Jury; Rinat Tabakman; Ad Cohen; Esmira Naftali; Bela Neiman; Efrat Halbfinger; Joseph A Murray; Arivarasu N Anbazhagan; Pradeep K Dudeja; Alexander Varvak; Jean-Christophe Leroux; Elena F Verdu
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

8.  Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier.

Authors:  Lael M Yonker; Tal Gilboa; Alana F Ogata; Yasmeen Senussi; Roey Lazarovits; Brittany P Boribong; Yannic C Bartsch; Maggie Loiselle; Magali Noval Rivas; Rebecca A Porritt; Rosiane Lima; Jameson P Davis; Eva J Farkas; Madeleine D Burns; Nicola Young; Vinay S Mahajan; Soroush Hajizadeh; Xcanda I Herrera Lopez; Johannes Kreuzer; Robert Morris; Enid E Martinez; Isaac Han; Kettner Griswold; Nicholas C Barry; David B Thompson; George Church; Andrea G Edlow; Wilhelm Haas; Shiv Pillai; Moshe Arditi; Galit Alter; David R Walt; Alessio Fasano
Journal:  J Clin Invest       Date:  2021-07-15       Impact factor: 14.808

Review 9.  Novel therapeutic/integrative approaches for celiac disease and dermatitis herpetiformis.

Authors:  Alessio Fasano
Journal:  Clin Dev Immunol       Date:  2012-10-10

Review 10.  Animal models to study gluten sensitivity.

Authors:  Eric V Marietta; Joseph A Murray
Journal:  Semin Immunopathol       Date:  2012-05-11       Impact factor: 11.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.